Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1441 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.020 | 1.000 | 2 | 2014 | 2019 | ||||
Breast Carcinoma
|
2145 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma of lung
|
995 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2018 | 2018 | |||||
Childhood Acute Lymphoblastic Leukemia
|
259 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Childhood Kidney Wilms Tumor
|
36 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Childhood Leukemia
|
140 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2016 | 2016 | |||||
Endometriosis
|
207 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Esophageal carcinoma
|
170 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Esophageal Neoplasms
|
160 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Fuchs Endothelial Dystrophy
|
25 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2018 | 2018 | |||||
leukemia
|
138 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of breast
|
2154 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of esophagus
|
169 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Malignant neoplasm of lung
|
1000 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2018 | 2018 | |||||
Nephroblastoma
|
56 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Primary malignant neoplasm of lung
|
981 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1 | 2018 | 2018 | |||||
Secondary malignant neoplasm of lymph node
|
188 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Squamous cell carcinoma of esophagus
|
320 | 0.701 | 0.440 | 11 | 61792609 | 5 prime UTR variant | G/A | snv | 0.34 | 0.26 | 0.010 | 1.000 | 1 | 2013 | 2013 |